Lumira Ventures

Lumira Ventures accounts for 19 tracked companies with verified cap-table data, 19 of which disclose round sizes totalling $4.5B. The median disclosed raise is $127M, and the largest is HistoSonics at $2.3B, ahead of Bardy Diagnostics ($375M) and Cardiac Dimensions ($200M).

The names that recur most often on these portfolio cap tables are Lumira Ventures (19 companies), Hatteras Venture Partners (2 companies), SV Health Investors (2 companies), Sofinnova Investments (2 companies), Alexandria Venture Investments (2 companies), OrbiMed (2 companies). By latest disclosed round, the market skews Series B (7), Series A (5), Growth (2), IPO (1).

• Companies tracked: 19
• Disclosed funding total: $4.5B across 19 companies
• Median disclosed raise: $127M
• Largest raise: HistoSonics — $2.3B
• Stage mix: Series B 7 · Series A 5 · Growth 2 · IPO 1
• Most recent dated round: 2026-06-03

Best funded Lumira Ventures companies

1. HistoSonics — $2.3B (latest: IPO)
2. Bardy Diagnostics — $375M (latest: Series B)
3. Cardiac Dimensions — $200M (latest: Series E)
4. Corvia Medical — $163M (latest: Series U)
5. Axonis Therapeutics — $157M (latest: Series A)
6. Congruence Therapeutics — $140M (latest: Series B)
7. Endogenex — $138M (latest: Series C)
8. enGene — $135M (latest: Growth)
9. Cour Pharmaceuticals Development — $135M (latest: Series A)
10. BioTheryX — $127M
11. XyloCor Therapeutics — $108M (latest: Series B)
12. Notch Therapeutics — $85M (latest: Series A)
13. OncoMyx Therapeutics — $75M (latest: Series B)
14. Think Research — $71M (latest: Growth)
15. Puzzle Medical Devices — $64M (latest: Series A)

Lumira Ventures — related firms and companies (56)

• HistoSonics
• Bardy Diagnostics
• Cardiac Dimensions
• Corvia Medical
• Axonis Therapeutics
• Congruence Therapeutics
• Endogenex
• enGene
• Notch Therapeutics
• Investors like Point72 Ventures
• BioTheryX
• Investors like Zetta Venture Partners
• Investors like Menlo Ventures
• Investors like Founder Collective
• Investors like Accomplice
• Investors like F-Prime
• Investors like Ventioneers
• Investors like Casdin Capital
• Investors like 500 Global
• Investors like Uncork Capital
• Investors like ACME Capital
• Investors like Acre Venture Partners
• Investors like Canapi Ventures
• Investors like General Catalyst
• Investors like Liquid 2 Ventures
• Investors like Lumira Ventures
• Investors like Foundry Group
• Contraline
• Investors like GIC
• KisoJi Biotechnology
• Investors like Upfront Ventures
• Puzzle Medical Devices
• Investors like DCM Ventures
• OncoMyx Therapeutics
• Investors like Vine Ventures
• XyloCor Therapeutics
• Investors like Greycroft
• Cour Pharmaceuticals Development
• Investors like Contour Venture Partners
• Investors like SoftBank Vision Fund
• Investors like Bienville Capital
• Investors like Bain Capital Ventures
• Investors like Goldman Sachs
• Investors like Torch Capital
• Investors like Motivate Venture Capital
• Investors like Altos Ventures
• Investors like Accel
• Investors like Spark Capital
• Investors like Polaris Partners
• Investors like Digital Currency Group
• Companies backed by Lumira Ventures
• Investors like Expansion Venture Capital
• Lumira Ventures co-investors 2026
• Investors like Initialized Capital
• PIC Therapeutics
• Investors like Techstars Ventures

Lumira Ventures alternatives · All research reports